They noticed that 84% of pancreatic ductal adenocarcinomas (PDAC) stained positive for HNF1B while 94% of the metastatic cases and a rather high percentage among the biliary, kidney, and ovarian stained positive for HNF1B as well. This evidence concerns the gene HNF1B and pancreatic ductal adenocarcinoma.